There are nearly 10,000 lawsuits pending in multidistrict litigation in federal court in Illinois over personal injuries allegedly caused by the contraceptive drugs Yasmin and Yaz.<\/p>\n
The U.S. Judicial Panel on Multidistrict Litigation (MDL) said that 9,961 actions were pending in the Yasmin\/Yaz MDL as of May 14. The MDL is No. 2100 in U.S. District Court, Southern District of Illinois. Bayer Healthcare Pharmaceuticals is the manufacturer of both Yasmin, which received FDA approval in 2001, and Yaz, which was approved by the FDA in 2006. Both drugs are oral contraceptives that combine a fourth generation progestin, drospirenone, with estrogen to prevent pregnancy.<\/p>\n
The lawsuits against Bayer allege that the plaintiffs developed serious medical issues caused by their use of Yasmin or Yaz. The injuries include gall bladder complications, stroke, deep vein thrombosis, heart blockage and blood clots.<\/p>\n
Bayer Pharmaceuticals said in its February 28, 2013 annual report that it had reached agreements to (more…)<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":" There are nearly 10,000 lawsuits pending in multidistrict litigation in federal court in Illinois over personal injuries allegedly caused by the contraceptive drugs Yasmin and Yaz. The U.S. Judicial Panel on Multidistrict Litigation (MDL) said that 9,961 actions were pending…<\/span><\/p>\n